Skip to content

A prospective, single-center, controlled clinical trial on the safety and efficacy of light-cured wound closure adhesives in the postoperative wound treatment of mixed hemorrhoid

A prospective, single-center, controlled clinical trial on the safety and efficacy of light-cured wound closure adhesives in the postoperative wound treatment of mixed hemorrhoid

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095212
Enrollment
Unknown
Registered
2025-01-03
Start date
2025-01-06
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mixed hemorrhoid

Interventions

Experimental group:Intraoperative management: The patient first underwent Milligan-Morgan hemorrhoidectomy. After the operation, the wound was rinsed and sterilized with metronidazole solution and dri
Control group:Intraoperative management: The patient first underwent Milligan-Morgan hemorrhoidectomy. After the operation, the wound was rinsed and sterilized with metronidazole solution and dried wi

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Hemorrhoidal patients who meet the required diagnostic criteria for mixed hemorrhoids; (2) No contraindications to surgery, and those who intend to undergo Milligan-Morgan hemorrhoidectomy in the Department of Proctology of Yueyang Hospital; (3) Age >= 18 years old and = 65 years old, gender is not limited; (4) The number of hemorrhoids is less than 3; (5) Understand and agree to participate in this study, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1)Patients with a combined history of other anorectal diseases or a history of surgery (including colorectal malignancy, Crohn's disease, ulcerative colitis, intestinal tuberculosis, etc.); (2)Those with serious heart, liver, kidney, lung insufficiency and other diseases; (3)Those with a history of uncontrollable psychosis; (4)Patients with mixed hemorrhoids in an incarcerated state; (5) Subjects with uncontrolled diabetes or diseases or conditions known to affect the wound healing process; (6)Persons with a known allergy to the components of this medical bioadhesive. (7)Subjects who require additional use of drugs or devices that affect wound healing, such as topical growth factors, in the test area; (8)Have participated or are participating in other clinical studies in the last 3 months; (9)Any medical history that, in the judgment of the investigator, is likely to interfere with the results of the trial or increase the risk to the patient.

Design outcomes

Primary

MeasureTime frame
Cure rate of wound healing at 18 days postoperatively;

Secondary

MeasureTime frame
Wound healing time;Postoperative pain;Postoperative wound edema;Skin allergy;Wound infection;Security Indicators;

Countries

China

Contacts

Public ContactHan Changpeng

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

13918314533@163.com+86 139 1831 4533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026